Does Acyclovir Cause Long-Term Side Effects with Prolonged Use?
Acyclovir, an antiviral used for herpes infections, is generally safe for short-term use, but prolonged or high-dose therapy raises concerns about cumulative effects, especially in patients with kidney issues or on suppressive therapy for conditions like herpes zoster or HIV-related infections.[1] Most data comes from clinical studies and post-marketing reports, showing rare but notable risks with extended exposure.
Kidney Damage from Long-Term Use
Prolonged acyclovir can lead to nephrotoxicity, including acute kidney injury or chronic renal impairment. Intravenous forms crystallize in renal tubules, causing obstruction, while oral use in dehydrated patients or those with pre-existing kidney disease accumulates the drug, worsening function over time. Studies report reversible creatinine rises in 5-10% of long-term users, but irreversible damage occurs in cases of repeated high doses.[2][3]
Neurological Risks Over Extended Periods
Rare neurotoxicity emerges with chronic use, particularly in elderly patients or those with renal failure. Symptoms include confusion, hallucinations, tremors, seizures, and encephalopathy. Case reports link these to drug accumulation, with resolution upon discontinuation, but repeated episodes may cause persistent cognitive deficits.[4]
Hematologic and Liver Effects
Long-term use occasionally triggers anemia, thrombocytopenia, or leukopenia, seen in bone marrow suppression during prolonged suppressive therapy for immunocompromised patients. Elevated liver enzymes occur in under 1% of cases, potentially progressing to hepatitis-like injury with very extended use.[1][5]
Resistance and Rebound Infections
Prolonged acyclovir selects for resistant herpes viruses, especially in immunocompromised individuals on daily therapy. This leads to treatment failure, requiring more toxic alternatives like foscarnet, and increases risk of disseminated infections long-term.[6]
What Happens in Patients on Lifelong Suppression?
For those on indefinite therapy (e.g., HIV patients or transplant recipients), monitoring includes quarterly kidney function tests and viral resistance screening. Risks rise after 6-12 months, with 20-30% developing subclinical renal changes.[3][7] No strong evidence links it to cancer or fertility issues.
[1]: FDA Label for Acyclovir
[2]: NEJM Review on Antiviral Nephrotoxicity
[3]: Clinical Pharmacology & Therapeutics Study
[4]: Journal of Antimicrobial Chemotherapy Case Series
[5]: Drugs.com Side Effects Database
[6]: CDC Guidelines on Antiviral Resistance
[7]: AIDS Research and Therapy Long-Term Data